nodes	percent_of_prediction	percent_of_DWPC	metapath
Nalbuphine—Naloxone—TLR4—obesity	0.00451	0.711	CrCbGaD
Nalbuphine—Erythema—Diethylpropion—obesity	0.00258	0.00433	CcSEcCtD
Nalbuphine—Euphoric mood—Sibutramine—obesity	0.00257	0.00433	CcSEcCtD
Nalbuphine—Hypertension—Phentermine—obesity	0.00256	0.0043	CcSEcCtD
Nalbuphine—Confusional state—Phenylpropanolamine—obesity	0.00255	0.00428	CcSEcCtD
Nalbuphine—Wheezing—Bupropion—obesity	0.00254	0.00427	CcSEcCtD
Nalbuphine—Tension—Diethylpropion—obesity	0.00253	0.00425	CcSEcCtD
Nalbuphine—Nervousness—Diethylpropion—obesity	0.0025	0.00421	CcSEcCtD
Nalbuphine—Hypersensitivity—Methamphetamine—obesity	0.00248	0.00417	CcSEcCtD
Nalbuphine—Dry mouth—Phentermine—obesity	0.00247	0.00415	CcSEcCtD
Nalbuphine—Redness—Topiramate—obesity	0.00247	0.00415	CcSEcCtD
Nalbuphine—Tachycardia—Phenylpropanolamine—obesity	0.00247	0.00415	CcSEcCtD
Nalbuphine—Vision blurred—Diethylpropion—obesity	0.00243	0.00408	CcSEcCtD
Nalbuphine—Oedema—Phentermine—obesity	0.00242	0.00407	CcSEcCtD
Nalbuphine—Tremor—Diethylpropion—obesity	0.00241	0.00406	CcSEcCtD
Nalbuphine—Hypersensitivity—Benzphetamine—obesity	0.00239	0.00402	CcSEcCtD
Nalbuphine—Depersonalisation—Topiramate—obesity	0.00237	0.00399	CcSEcCtD
Nalbuphine—Agitation—Diethylpropion—obesity	0.00237	0.00398	CcSEcCtD
Nalbuphine—Hypotension—Phenylpropanolamine—obesity	0.00236	0.00397	CcSEcCtD
Nalbuphine—Tachycardia—Phentermine—obesity	0.00236	0.00397	CcSEcCtD
Nalbuphine—Delusion—Topiramate—obesity	0.00235	0.00396	CcSEcCtD
Nalbuphine—Abdominal pain—Phendimetrazine—obesity	0.00234	0.00393	CcSEcCtD
Nalbuphine—Agitation—Cimetidine—obesity	0.00225	0.00379	CcSEcCtD
Nalbuphine—Dyspnoea—Phenylpropanolamine—obesity	0.00225	0.00379	CcSEcCtD
Nalbuphine—Somnolence—Phenylpropanolamine—obesity	0.00225	0.00378	CcSEcCtD
Nalbuphine—Euphoric mood—Bupropion—obesity	0.00224	0.00378	CcSEcCtD
Nalbuphine—Convulsion—Diethylpropion—obesity	0.00223	0.00376	CcSEcCtD
Nalbuphine—Dizziness—Methamphetamine—obesity	0.00223	0.00374	CcSEcCtD
Nalbuphine—Anxiety—Diethylpropion—obesity	0.00219	0.00368	CcSEcCtD
Nalbuphine—Dizziness—Benzphetamine—obesity	0.00215	0.00361	CcSEcCtD
Nalbuphine—Dry mouth—Diethylpropion—obesity	0.00215	0.00361	CcSEcCtD
Nalbuphine—Dyspepsia—Phentermine—obesity	0.00213	0.00358	CcSEcCtD
Nalbuphine—Headache—Methamphetamine—obesity	0.00211	0.00355	CcSEcCtD
Nalbuphine—Feeling abnormal—Phenylpropanolamine—obesity	0.00208	0.0035	CcSEcCtD
Nalbuphine—Anxiety—Cimetidine—obesity	0.00208	0.0035	CcSEcCtD
Nalbuphine—Cardiac arrest—Sibutramine—obesity	0.00207	0.00348	CcSEcCtD
Nalbuphine—Tachycardia—Diethylpropion—obesity	0.00205	0.00345	CcSEcCtD
Nalbuphine—Hyperhidrosis—Diethylpropion—obesity	0.00203	0.00342	CcSEcCtD
Nalbuphine—Headache—Benzphetamine—obesity	0.00203	0.00342	CcSEcCtD
Nalbuphine—Cramp muscle—Orlistat—obesity	0.00202	0.0034	CcSEcCtD
Nalbuphine—Confusional state—Cimetidine—obesity	0.00202	0.00339	CcSEcCtD
Nalbuphine—Dizziness—Phendimetrazine—obesity	0.00196	0.00329	CcSEcCtD
Nalbuphine—Tachycardia—Cimetidine—obesity	0.00195	0.00328	CcSEcCtD
Nalbuphine—Asthma—Orlistat—obesity	0.00194	0.00327	CcSEcCtD
Nalbuphine—Speech disorder—Topiramate—obesity	0.00194	0.00325	CcSEcCtD
Nalbuphine—Nausea—Benzphetamine—obesity	0.00193	0.00324	CcSEcCtD
Nalbuphine—Sensory loss—Topiramate—obesity	0.00192	0.00323	CcSEcCtD
Nalbuphine—Urticaria—Phentermine—obesity	0.00192	0.00323	CcSEcCtD
Nalbuphine—Abdominal pain—Phentermine—obesity	0.00191	0.00321	CcSEcCtD
Nalbuphine—Bronchospasm—Orlistat—obesity	0.00191	0.00321	CcSEcCtD
Nalbuphine—Sweating increased—Orlistat—obesity	0.00189	0.00318	CcSEcCtD
Nalbuphine—Asthma—Sibutramine—obesity	0.00188	0.00316	CcSEcCtD
Nalbuphine—Dyspnoea—Diethylpropion—obesity	0.00187	0.00315	CcSEcCtD
Nalbuphine—Somnolence—Diethylpropion—obesity	0.00187	0.00314	CcSEcCtD
Nalbuphine—Hypersensitivity—Phenylpropanolamine—obesity	0.00186	0.00313	CcSEcCtD
Nalbuphine—Headache—Phendimetrazine—obesity	0.00185	0.00312	CcSEcCtD
Nalbuphine—Dyspepsia—Diethylpropion—obesity	0.00185	0.00311	CcSEcCtD
Nalbuphine—Somnolence—Cimetidine—obesity	0.00178	0.00299	CcSEcCtD
Nalbuphine—Nausea—Phendimetrazine—obesity	0.00176	0.00295	CcSEcCtD
Nalbuphine—Pollakiuria—Sibutramine—obesity	0.00174	0.00292	CcSEcCtD
Nalbuphine—Asthenia—Phentermine—obesity	0.00173	0.00292	CcSEcCtD
Nalbuphine—Feeling abnormal—Diethylpropion—obesity	0.00173	0.00291	CcSEcCtD
Nalbuphine—Depression—Orlistat—obesity	0.00173	0.00291	CcSEcCtD
Nalbuphine—Cramp muscle—Bupropion—obesity	0.00171	0.00287	CcSEcCtD
Nalbuphine—Depression—Sibutramine—obesity	0.00167	0.00281	CcSEcCtD
Nalbuphine—Urticaria—Diethylpropion—obesity	0.00167	0.00281	CcSEcCtD
Nalbuphine—Dizziness—Phenylpropanolamine—obesity	0.00167	0.00281	CcSEcCtD
Nalbuphine—Feeling abnormal—Cimetidine—obesity	0.00165	0.00277	CcSEcCtD
Nalbuphine—Asthma—Bupropion—obesity	0.00164	0.00276	CcSEcCtD
Nalbuphine—Bronchospasm—Bupropion—obesity	0.00161	0.00271	CcSEcCtD
Nalbuphine—Vomiting—Phenylpropanolamine—obesity	0.00161	0.0027	CcSEcCtD
Nalbuphine—Dizziness—Phentermine—obesity	0.0016	0.00269	CcSEcCtD
Nalbuphine—Sweating increased—Bupropion—obesity	0.0016	0.00269	CcSEcCtD
Nalbuphine—Rash—Phenylpropanolamine—obesity	0.00159	0.00268	CcSEcCtD
Nalbuphine—Dermatitis—Phenylpropanolamine—obesity	0.00159	0.00268	CcSEcCtD
Nalbuphine—Body temperature increased—Cimetidine—obesity	0.00158	0.00266	CcSEcCtD
Nalbuphine—Vomiting—Phentermine—obesity	0.00154	0.00259	CcSEcCtD
Nalbuphine—Bradycardia—Sibutramine—obesity	0.00153	0.00258	CcSEcCtD
Nalbuphine—Rash—Phentermine—obesity	0.00152	0.00256	CcSEcCtD
Nalbuphine—Dermatitis—Phentermine—obesity	0.00152	0.00256	CcSEcCtD
Nalbuphine—Headache—Phentermine—obesity	0.00151	0.00255	CcSEcCtD
Nalbuphine—Pollakiuria—Bupropion—obesity	0.00151	0.00255	CcSEcCtD
Nalbuphine—Nausea—Phenylpropanolamine—obesity	0.0015	0.00252	CcSEcCtD
Nalbuphine—Hypoaesthesia—Sibutramine—obesity	0.0015	0.00252	CcSEcCtD
Nalbuphine—Hypersensitivity—Cimetidine—obesity	0.00147	0.00248	CcSEcCtD
Nalbuphine—Nausea—Phentermine—obesity	0.00144	0.00242	CcSEcCtD
Nalbuphine—Asthenia—Cimetidine—obesity	0.00144	0.00241	CcSEcCtD
Nalbuphine—Euphoric mood—Topiramate—obesity	0.00143	0.00241	CcSEcCtD
Nalbuphine—Dizziness—Diethylpropion—obesity	0.00139	0.00234	CcSEcCtD
Nalbuphine—Vomiting—Diethylpropion—obesity	0.00134	0.00225	CcSEcCtD
Nalbuphine—Rash—Diethylpropion—obesity	0.00133	0.00223	CcSEcCtD
Nalbuphine—Dysgeusia—Orlistat—obesity	0.00133	0.00223	CcSEcCtD
Nalbuphine—Dermatitis—Diethylpropion—obesity	0.00132	0.00223	CcSEcCtD
Nalbuphine—Dizziness—Cimetidine—obesity	0.00132	0.00223	CcSEcCtD
Nalbuphine—Headache—Diethylpropion—obesity	0.00132	0.00222	CcSEcCtD
Nalbuphine—Hallucination—Bupropion—obesity	0.00131	0.0022	CcSEcCtD
Nalbuphine—Hypoaesthesia—Bupropion—obesity	0.00131	0.0022	CcSEcCtD
Nalbuphine—Muscle spasms—Orlistat—obesity	0.0013	0.00219	CcSEcCtD
Nalbuphine—Tension—Sibutramine—obesity	0.00129	0.00216	CcSEcCtD
Nalbuphine—Dysgeusia—Sibutramine—obesity	0.00128	0.00216	CcSEcCtD
Nalbuphine—Vision blurred—Orlistat—obesity	0.00128	0.00215	CcSEcCtD
Nalbuphine—Nervousness—Sibutramine—obesity	0.00127	0.00214	CcSEcCtD
Nalbuphine—Vomiting—Cimetidine—obesity	0.00127	0.00214	CcSEcCtD
Nalbuphine—Naloxone—ESR1—obesity	0.00127	0.2	CrCbGaD
Nalbuphine—Rash—Cimetidine—obesity	0.00126	0.00212	CcSEcCtD
Nalbuphine—Dermatitis—Cimetidine—obesity	0.00126	0.00212	CcSEcCtD
Nalbuphine—Muscle spasms—Sibutramine—obesity	0.00126	0.00212	CcSEcCtD
Nalbuphine—Headache—Cimetidine—obesity	0.00125	0.00211	CcSEcCtD
Nalbuphine—Nausea—Diethylpropion—obesity	0.00125	0.0021	CcSEcCtD
Nalbuphine—Vision blurred—Sibutramine—obesity	0.00123	0.00208	CcSEcCtD
Nalbuphine—Tremor—Sibutramine—obesity	0.00123	0.00206	CcSEcCtD
Nalbuphine—Flushing—Bupropion—obesity	0.00122	0.00205	CcSEcCtD
Nalbuphine—Vertigo—Orlistat—obesity	0.00122	0.00205	CcSEcCtD
Nalbuphine—Agitation—Sibutramine—obesity	0.0012	0.00202	CcSEcCtD
Nalbuphine—Nausea—Cimetidine—obesity	0.00119	0.002	CcSEcCtD
Nalbuphine—Vertigo—Sibutramine—obesity	0.00118	0.00198	CcSEcCtD
Nalbuphine—Syncope—Sibutramine—obesity	0.00117	0.00198	CcSEcCtD
Nalbuphine—Convulsion—Orlistat—obesity	0.00117	0.00197	CcSEcCtD
Nalbuphine—Loss of consciousness—Sibutramine—obesity	0.00115	0.00194	CcSEcCtD
Nalbuphine—Anxiety—Orlistat—obesity	0.00115	0.00193	CcSEcCtD
Nalbuphine—Convulsion—Sibutramine—obesity	0.00114	0.00191	CcSEcCtD
Nalbuphine—Hypertension—Sibutramine—obesity	0.00113	0.0019	CcSEcCtD
Nalbuphine—Dry mouth—Orlistat—obesity	0.00113	0.0019	CcSEcCtD
Nalbuphine—Tension—Bupropion—obesity	0.00112	0.00189	CcSEcCtD
Nalbuphine—Dysgeusia—Bupropion—obesity	0.00112	0.00188	CcSEcCtD
Nalbuphine—Anxiety—Sibutramine—obesity	0.00111	0.00187	CcSEcCtD
Nalbuphine—Nervousness—Bupropion—obesity	0.00111	0.00187	CcSEcCtD
Nalbuphine—Oedema—Orlistat—obesity	0.0011	0.00186	CcSEcCtD
Nalbuphine—Muscle spasms—Bupropion—obesity	0.0011	0.00185	CcSEcCtD
Nalbuphine—Dry mouth—Sibutramine—obesity	0.00109	0.00183	CcSEcCtD
Nalbuphine—Confusional state—Sibutramine—obesity	0.00108	0.00181	CcSEcCtD
Nalbuphine—Vision blurred—Bupropion—obesity	0.00108	0.00181	CcSEcCtD
Nalbuphine—Tremor—Bupropion—obesity	0.00107	0.0018	CcSEcCtD
Nalbuphine—Oedema—Sibutramine—obesity	0.00107	0.0018	CcSEcCtD
Nalbuphine—Hyperhidrosis—Orlistat—obesity	0.00107	0.0018	CcSEcCtD
Nalbuphine—Shock—Sibutramine—obesity	0.00105	0.00177	CcSEcCtD
Nalbuphine—Agitation—Bupropion—obesity	0.00105	0.00177	CcSEcCtD
Nalbuphine—Asthma—Topiramate—obesity	0.00104	0.00176	CcSEcCtD
Nalbuphine—Tachycardia—Sibutramine—obesity	0.00104	0.00176	CcSEcCtD
Nalbuphine—Hyperhidrosis—Sibutramine—obesity	0.00103	0.00174	CcSEcCtD
Nalbuphine—Vertigo—Bupropion—obesity	0.00103	0.00173	CcSEcCtD
Nalbuphine—Syncope—Bupropion—obesity	0.00102	0.00172	CcSEcCtD
Nalbuphine—Sweating increased—Topiramate—obesity	0.00102	0.00171	CcSEcCtD
Nalbuphine—Loss of consciousness—Bupropion—obesity	0.001	0.00169	CcSEcCtD
Nalbuphine—Hypotension—Sibutramine—obesity	0.000999	0.00168	CcSEcCtD
Nalbuphine—Paraesthesia—Orlistat—obesity	0.000992	0.00167	CcSEcCtD
Nalbuphine—Convulsion—Bupropion—obesity	0.000989	0.00166	CcSEcCtD
Nalbuphine—Hypertension—Bupropion—obesity	0.000986	0.00166	CcSEcCtD
Nalbuphine—Dyspepsia—Orlistat—obesity	0.000972	0.00164	CcSEcCtD
Nalbuphine—Anxiety—Bupropion—obesity	0.000969	0.00163	CcSEcCtD
Nalbuphine—Pollakiuria—Topiramate—obesity	0.000965	0.00162	CcSEcCtD
Nalbuphine—Paraesthesia—Sibutramine—obesity	0.00096	0.00161	CcSEcCtD
Nalbuphine—Dyspnoea—Sibutramine—obesity	0.000953	0.0016	CcSEcCtD
Nalbuphine—Dry mouth—Bupropion—obesity	0.000951	0.0016	CcSEcCtD
Nalbuphine—Somnolence—Sibutramine—obesity	0.00095	0.0016	CcSEcCtD
Nalbuphine—Dyspepsia—Sibutramine—obesity	0.000941	0.00158	CcSEcCtD
Nalbuphine—Confusional state—Bupropion—obesity	0.00094	0.00158	CcSEcCtD
Nalbuphine—Oedema—Bupropion—obesity	0.000932	0.00157	CcSEcCtD
Nalbuphine—Depression—Topiramate—obesity	0.000928	0.00156	CcSEcCtD
Nalbuphine—Shock—Bupropion—obesity	0.000917	0.00154	CcSEcCtD
Nalbuphine—Feeling abnormal—Orlistat—obesity	0.00091	0.00153	CcSEcCtD
Nalbuphine—Tachycardia—Bupropion—obesity	0.00091	0.00153	CcSEcCtD
Nalbuphine—Gastrointestinal pain—Orlistat—obesity	0.000903	0.00152	CcSEcCtD
Nalbuphine—Hyperhidrosis—Bupropion—obesity	0.000901	0.00152	CcSEcCtD
Nalbuphine—Feeling abnormal—Sibutramine—obesity	0.000881	0.00148	CcSEcCtD
Nalbuphine—Urticaria—Orlistat—obesity	0.000878	0.00148	CcSEcCtD
Nalbuphine—Gastrointestinal pain—Sibutramine—obesity	0.000874	0.00147	CcSEcCtD
Nalbuphine—Abdominal pain—Orlistat—obesity	0.000873	0.00147	CcSEcCtD
Nalbuphine—Body temperature increased—Orlistat—obesity	0.000873	0.00147	CcSEcCtD
Nalbuphine—Hypotension—Bupropion—obesity	0.000871	0.00146	CcSEcCtD
Nalbuphine—Bradycardia—Topiramate—obesity	0.000851	0.00143	CcSEcCtD
Nalbuphine—Urticaria—Sibutramine—obesity	0.000849	0.00143	CcSEcCtD
Nalbuphine—Abdominal pain—Sibutramine—obesity	0.000845	0.00142	CcSEcCtD
Nalbuphine—Body temperature increased—Sibutramine—obesity	0.000845	0.00142	CcSEcCtD
Nalbuphine—Paraesthesia—Bupropion—obesity	0.000837	0.00141	CcSEcCtD
Nalbuphine—Hallucination—Topiramate—obesity	0.000832	0.0014	CcSEcCtD
Nalbuphine—Hypoaesthesia—Topiramate—obesity	0.000832	0.0014	CcSEcCtD
Nalbuphine—Dyspnoea—Bupropion—obesity	0.000831	0.0014	CcSEcCtD
Nalbuphine—Somnolence—Bupropion—obesity	0.000829	0.00139	CcSEcCtD
Nalbuphine—Dyspepsia—Bupropion—obesity	0.00082	0.00138	CcSEcCtD
Nalbuphine—Hypersensitivity—Orlistat—obesity	0.000814	0.00137	CcSEcCtD
Nalbuphine—Asthenia—Orlistat—obesity	0.000793	0.00133	CcSEcCtD
Nalbuphine—Hypersensitivity—Sibutramine—obesity	0.000788	0.00132	CcSEcCtD
Nalbuphine—Pruritus—Orlistat—obesity	0.000782	0.00131	CcSEcCtD
Nalbuphine—Flushing—Topiramate—obesity	0.000776	0.0013	CcSEcCtD
Nalbuphine—Feeling abnormal—Bupropion—obesity	0.000768	0.00129	CcSEcCtD
Nalbuphine—Asthenia—Sibutramine—obesity	0.000767	0.00129	CcSEcCtD
Nalbuphine—Gastrointestinal pain—Bupropion—obesity	0.000762	0.00128	CcSEcCtD
Nalbuphine—Pruritus—Sibutramine—obesity	0.000756	0.00127	CcSEcCtD
Nalbuphine—Urticaria—Bupropion—obesity	0.00074	0.00125	CcSEcCtD
Nalbuphine—Abdominal pain—Bupropion—obesity	0.000737	0.00124	CcSEcCtD
Nalbuphine—Body temperature increased—Bupropion—obesity	0.000737	0.00124	CcSEcCtD
Nalbuphine—Dizziness—Orlistat—obesity	0.000731	0.00123	CcSEcCtD
Nalbuphine—Erythema—Topiramate—obesity	0.000728	0.00122	CcSEcCtD
Nalbuphine—Tension—Topiramate—obesity	0.000714	0.0012	CcSEcCtD
Nalbuphine—Dysgeusia—Topiramate—obesity	0.000713	0.0012	CcSEcCtD
Nalbuphine—Dizziness—Sibutramine—obesity	0.000707	0.00119	CcSEcCtD
Nalbuphine—Nervousness—Topiramate—obesity	0.000707	0.00119	CcSEcCtD
Nalbuphine—Vomiting—Orlistat—obesity	0.000702	0.00118	CcSEcCtD
Nalbuphine—Muscle spasms—Topiramate—obesity	0.0007	0.00118	CcSEcCtD
Nalbuphine—Rash—Orlistat—obesity	0.000697	0.00117	CcSEcCtD
Nalbuphine—Dermatitis—Orlistat—obesity	0.000696	0.00117	CcSEcCtD
Nalbuphine—Headache—Orlistat—obesity	0.000692	0.00116	CcSEcCtD
Nalbuphine—Hypersensitivity—Bupropion—obesity	0.000687	0.00116	CcSEcCtD
Nalbuphine—Vision blurred—Topiramate—obesity	0.000686	0.00115	CcSEcCtD
Nalbuphine—Tremor—Topiramate—obesity	0.000682	0.00115	CcSEcCtD
Nalbuphine—Vomiting—Sibutramine—obesity	0.00068	0.00114	CcSEcCtD
Nalbuphine—Rash—Sibutramine—obesity	0.000674	0.00113	CcSEcCtD
Nalbuphine—Dermatitis—Sibutramine—obesity	0.000673	0.00113	CcSEcCtD
Nalbuphine—Headache—Sibutramine—obesity	0.00067	0.00113	CcSEcCtD
Nalbuphine—Asthenia—Bupropion—obesity	0.000669	0.00112	CcSEcCtD
Nalbuphine—Agitation—Topiramate—obesity	0.000669	0.00112	CcSEcCtD
Nalbuphine—Pruritus—Bupropion—obesity	0.000659	0.00111	CcSEcCtD
Nalbuphine—Nausea—Orlistat—obesity	0.000656	0.0011	CcSEcCtD
Nalbuphine—Vertigo—Topiramate—obesity	0.000654	0.0011	CcSEcCtD
Nalbuphine—Syncope—Topiramate—obesity	0.000652	0.0011	CcSEcCtD
Nalbuphine—Loss of consciousness—Topiramate—obesity	0.00064	0.00108	CcSEcCtD
Nalbuphine—Nausea—Sibutramine—obesity	0.000635	0.00107	CcSEcCtD
Nalbuphine—Convulsion—Topiramate—obesity	0.00063	0.00106	CcSEcCtD
Nalbuphine—Hypertension—Topiramate—obesity	0.000628	0.00106	CcSEcCtD
Nalbuphine—Anxiety—Topiramate—obesity	0.000617	0.00104	CcSEcCtD
Nalbuphine—Dizziness—Bupropion—obesity	0.000616	0.00104	CcSEcCtD
Nalbuphine—Dry mouth—Topiramate—obesity	0.000606	0.00102	CcSEcCtD
Nalbuphine—Confusional state—Topiramate—obesity	0.000599	0.00101	CcSEcCtD
Nalbuphine—Oedema—Topiramate—obesity	0.000594	0.000999	CcSEcCtD
Nalbuphine—Vomiting—Bupropion—obesity	0.000593	0.000997	CcSEcCtD
Nalbuphine—Rash—Bupropion—obesity	0.000588	0.000988	CcSEcCtD
Nalbuphine—Dermatitis—Bupropion—obesity	0.000587	0.000988	CcSEcCtD
Nalbuphine—Shock—Topiramate—obesity	0.000584	0.000983	CcSEcCtD
Nalbuphine—Headache—Bupropion—obesity	0.000584	0.000982	CcSEcCtD
Nalbuphine—Tachycardia—Topiramate—obesity	0.00058	0.000975	CcSEcCtD
Nalbuphine—Hyperhidrosis—Topiramate—obesity	0.000574	0.000966	CcSEcCtD
Nalbuphine—Naloxone—ALB—obesity	0.000563	0.0888	CrCbGaD
Nalbuphine—Hypotension—Topiramate—obesity	0.000555	0.000933	CcSEcCtD
Nalbuphine—Nausea—Bupropion—obesity	0.000554	0.000931	CcSEcCtD
Nalbuphine—Paraesthesia—Topiramate—obesity	0.000533	0.000897	CcSEcCtD
Nalbuphine—Dyspnoea—Topiramate—obesity	0.000529	0.00089	CcSEcCtD
Nalbuphine—Somnolence—Topiramate—obesity	0.000528	0.000888	CcSEcCtD
Nalbuphine—Dyspepsia—Topiramate—obesity	0.000523	0.000879	CcSEcCtD
Nalbuphine—Feeling abnormal—Topiramate—obesity	0.000489	0.000823	CcSEcCtD
Nalbuphine—Gastrointestinal pain—Topiramate—obesity	0.000486	0.000817	CcSEcCtD
Nalbuphine—Urticaria—Topiramate—obesity	0.000472	0.000793	CcSEcCtD
Nalbuphine—Body temperature increased—Topiramate—obesity	0.000469	0.00079	CcSEcCtD
Nalbuphine—Abdominal pain—Topiramate—obesity	0.000469	0.00079	CcSEcCtD
Nalbuphine—Hypersensitivity—Topiramate—obesity	0.000438	0.000736	CcSEcCtD
Nalbuphine—Asthenia—Topiramate—obesity	0.000426	0.000717	CcSEcCtD
Nalbuphine—Pruritus—Topiramate—obesity	0.00042	0.000707	CcSEcCtD
Nalbuphine—Dizziness—Topiramate—obesity	0.000393	0.00066	CcSEcCtD
Nalbuphine—Vomiting—Topiramate—obesity	0.000378	0.000635	CcSEcCtD
Nalbuphine—Rash—Topiramate—obesity	0.000374	0.00063	CcSEcCtD
Nalbuphine—Dermatitis—Topiramate—obesity	0.000374	0.000629	CcSEcCtD
Nalbuphine—Headache—Topiramate—obesity	0.000372	0.000626	CcSEcCtD
Nalbuphine—Nausea—Topiramate—obesity	0.000353	0.000593	CcSEcCtD
Nalbuphine—OPRK1—GPCR downstream signaling—PIK3CG—obesity	6.96e-05	0.000174	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—GHRL—obesity	6.88e-05	0.000172	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—PARP1—obesity	6.88e-05	0.000172	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—POMC—obesity	6.86e-05	0.000172	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—PRL—obesity	6.85e-05	0.000172	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—NPY—obesity	6.84e-05	0.000171	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—DRD4—obesity	6.82e-05	0.000171	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—APOC3—obesity	6.8e-05	0.00017	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—IAPP—obesity	6.8e-05	0.00017	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—STK11—obesity	6.75e-05	0.000169	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—CCL2—obesity	6.72e-05	0.000168	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—PLG—obesity	6.67e-05	0.000167	CbGpPWpGaD
Nalbuphine—OPRD1—GPCR downstream signaling—RHOA—obesity	6.66e-05	0.000167	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR downstream signaling—AGT—obesity	6.66e-05	0.000167	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR downstream signaling—POMC—obesity	6.63e-05	0.000166	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—F2—obesity	6.61e-05	0.000166	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—PRKCB—obesity	6.61e-05	0.000166	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—AKT2—obesity	6.6e-05	0.000165	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—HTR1B—obesity	6.6e-05	0.000165	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—CRH—obesity	6.6e-05	0.000165	CbGpPWpGaD
Nalbuphine—OPRD1—GPCR downstream signaling—PIK3R1—obesity	6.59e-05	0.000165	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—SDC1—obesity	6.52e-05	0.000163	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—CNR1—obesity	6.52e-05	0.000163	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—FOXO3—obesity	6.51e-05	0.000163	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—PRKCD—obesity	6.51e-05	0.000163	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—ADRB2—obesity	6.49e-05	0.000163	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—AKR1C3—obesity	6.42e-05	0.000161	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—TCF7L2—obesity	6.4e-05	0.00016	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—SOCS1—obesity	6.4e-05	0.00016	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR downstream signaling—AKT2—obesity	6.37e-05	0.00016	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—HTR2A—obesity	6.37e-05	0.00016	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—C3—obesity	6.36e-05	0.000159	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—DRD2—obesity	6.36e-05	0.000159	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—PIK3CD—obesity	6.34e-05	0.000159	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—PIK3CG—obesity	6.32e-05	0.000158	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—SOCS3—obesity	6.32e-05	0.000158	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—GCG—obesity	6.29e-05	0.000158	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—PTPN1—obesity	6.29e-05	0.000158	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—NPS—obesity	6.25e-05	0.000157	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—GNB3—obesity	6.18e-05	0.000155	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR downstream signaling—F2—obesity	6.15e-05	0.000154	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR downstream signaling—PRKCB—obesity	6.15e-05	0.000154	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—HTR2C—obesity	6.13e-05	0.000154	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—DRD1—obesity	6.13e-05	0.000154	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR downstream signaling—PIK3CD—obesity	6.12e-05	0.000153	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—TYK2—obesity	6.1e-05	0.000153	CbGpPWpGaD
Nalbuphine—OPRD1—GPCR downstream signaling—PIK3CB—obesity	6.08e-05	0.000152	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—IGF2—obesity	6.07e-05	0.000152	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—RHOA—obesity	6.05e-05	0.000152	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—AGT—obesity	6.04e-05	0.000151	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—GNAS—obesity	6.02e-05	0.000151	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—POMC—obesity	6.02e-05	0.000151	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—PRL—obesity	6e-05	0.00015	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—PIK3R1—obesity	5.99e-05	0.00015	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—NTRK2—obesity	5.97e-05	0.000149	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—ADRB1—obesity	5.94e-05	0.000149	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—STK11—obesity	5.92e-05	0.000148	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—APOB—obesity	5.9e-05	0.000148	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—CCL2—obesity	5.89e-05	0.000148	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR downstream signaling—PIK3CG—obesity	5.88e-05	0.000147	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—PLG—obesity	5.85e-05	0.000147	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR downstream signaling—RHOA—obesity	5.84e-05	0.000146	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—PARP1—obesity	5.81e-05	0.000146	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—GHRL—obesity	5.81e-05	0.000146	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—AKT2—obesity	5.79e-05	0.000145	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR downstream signaling—PIK3R1—obesity	5.78e-05	0.000145	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—DRD4—obesity	5.77e-05	0.000144	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—CCL5—obesity	5.76e-05	0.000144	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—FOXO3—obesity	5.71e-05	0.000143	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—ADRB2—obesity	5.69e-05	0.000143	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—LPL—obesity	5.63e-05	0.000141	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—SOCS1—obesity	5.61e-05	0.000141	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR downstream signaling—POMC—obesity	5.6e-05	0.00014	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—FOXO1—obesity	5.59e-05	0.00014	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—F2—obesity	5.58e-05	0.00014	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—PRKCB—obesity	5.58e-05	0.00014	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—RPS6KB1—obesity	5.58e-05	0.00014	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—PIK3CD—obesity	5.56e-05	0.000139	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—SOCS3—obesity	5.54e-05	0.000139	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—PIK3CB—obesity	5.53e-05	0.000138	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—CNR1—obesity	5.51e-05	0.000138	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—GNB3—obesity	5.42e-05	0.000136	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—TCF7L2—obesity	5.41e-05	0.000136	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR downstream signaling—AKT2—obesity	5.38e-05	0.000135	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—DRD2—obesity	5.37e-05	0.000135	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—TYK2—obesity	5.35e-05	0.000134	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—PIK3CG—obesity	5.34e-05	0.000134	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR downstream signaling—PIK3CB—obesity	5.34e-05	0.000134	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—IGF2—obesity	5.33e-05	0.000133	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—GCG—obesity	5.32e-05	0.000133	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—PTPN1—obesity	5.32e-05	0.000133	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—RHOA—obesity	5.3e-05	0.000133	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—GNAS—obesity	5.28e-05	0.000132	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—PIK3R1—obesity	5.25e-05	0.000132	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—PRKCD—obesity	5.19e-05	0.00013	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR downstream signaling—PIK3CD—obesity	5.17e-05	0.00013	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—APOB—obesity	5.17e-05	0.00013	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—POMC—obesity	5.09e-05	0.000127	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—HTR2A—obesity	5.08e-05	0.000127	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—PRL—obesity	5.07e-05	0.000127	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—C3—obesity	5.07e-05	0.000127	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—CCL5—obesity	5.05e-05	0.000127	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—STK11—obesity	5e-05	0.000125	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—CCL2—obesity	4.98e-05	0.000125	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—PLG—obesity	4.94e-05	0.000124	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—LPL—obesity	4.94e-05	0.000124	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR downstream signaling—RHOA—obesity	4.94e-05	0.000124	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—FOXO1—obesity	4.9e-05	0.000123	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—RPS6KB1—obesity	4.89e-05	0.000123	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—AKT2—obesity	4.89e-05	0.000123	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR downstream signaling—PIK3R1—obesity	4.89e-05	0.000122	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—PIK3CB—obesity	4.85e-05	0.000121	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—FOXO3—obesity	4.83e-05	0.000121	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—IRS2—obesity	4.82e-05	0.000121	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—AGT—obesity	4.82e-05	0.000121	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—ADRB2—obesity	4.81e-05	0.000121	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—SOCS1—obesity	4.74e-05	0.000119	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—APOE—obesity	4.72e-05	0.000118	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—LEP—obesity	4.72e-05	0.000118	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—PIK3CD—obesity	4.7e-05	0.000118	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—SOCS3—obesity	4.68e-05	0.000117	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—CAV1—obesity	4.68e-05	0.000117	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—APOA1—obesity	4.67e-05	0.000117	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—GNB3—obesity	4.58e-05	0.000115	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—PRKCD—obesity	4.55e-05	0.000114	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—TYK2—obesity	4.52e-05	0.000113	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR downstream signaling—PIK3CB—obesity	4.51e-05	0.000113	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—ESR1—obesity	4.51e-05	0.000113	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—IGF2—obesity	4.5e-05	0.000113	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—RHOA—obesity	4.48e-05	0.000112	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—GNAS—obesity	4.46e-05	0.000112	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—HTR2A—obesity	4.45e-05	0.000112	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—PRKCB—obesity	4.45e-05	0.000112	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—F2—obesity	4.45e-05	0.000112	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—C3—obesity	4.45e-05	0.000111	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—PIK3R1—obesity	4.44e-05	0.000111	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—BAD—obesity	4.4e-05	0.00011	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—APOB—obesity	4.37e-05	0.000109	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—CCL5—obesity	4.27e-05	0.000107	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—PIK3CG—obesity	4.26e-05	0.000107	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—IRS2—obesity	4.23e-05	0.000106	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—AGT—obesity	4.22e-05	0.000106	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—IRS1—obesity	4.21e-05	0.000105	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—LPL—obesity	4.17e-05	0.000105	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—FOXO1—obesity	4.14e-05	0.000104	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—APOE—obesity	4.14e-05	0.000104	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—LEP—obesity	4.14e-05	0.000104	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—RPS6KB1—obesity	4.14e-05	0.000104	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—CAV1—obesity	4.1e-05	0.000103	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—PIK3CB—obesity	4.09e-05	0.000103	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—APOA1—obesity	4.09e-05	0.000103	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—POMC—obesity	4.05e-05	0.000102	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—INS—obesity	4.03e-05	0.000101	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—CCL2—obesity	3.97e-05	9.94e-05	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—ESR1—obesity	3.95e-05	9.9e-05	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—PRKCB—obesity	3.9e-05	9.78e-05	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—F2—obesity	3.9e-05	9.78e-05	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—IGF1—obesity	3.9e-05	9.77e-05	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—AKT2—obesity	3.9e-05	9.76e-05	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—BAD—obesity	3.86e-05	9.66e-05	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—PRKCD—obesity	3.84e-05	9.63e-05	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—HTR2A—obesity	3.76e-05	9.43e-05	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—C3—obesity	3.76e-05	9.41e-05	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—PIK3CD—obesity	3.74e-05	9.38e-05	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—PIK3CG—obesity	3.74e-05	9.36e-05	CbGpPWpGaD
Nalbuphine—OPRD1—GPCR downstream signaling—PIK3CA—obesity	3.71e-05	9.29e-05	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—SERPINE1—obesity	3.7e-05	9.28e-05	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—IRS1—obesity	3.69e-05	9.25e-05	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—TYK2—obesity	3.6e-05	9.03e-05	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—IRS2—obesity	3.57e-05	8.96e-05	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—RHOA—obesity	3.57e-05	8.95e-05	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—AGT—obesity	3.57e-05	8.94e-05	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—POMC—obesity	3.56e-05	8.91e-05	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—NOS3—obesity	3.54e-05	8.86e-05	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—PIK3R1—obesity	3.54e-05	8.86e-05	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—INS—obesity	3.54e-05	8.86e-05	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—LEP—obesity	3.5e-05	8.76e-05	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—APOE—obesity	3.5e-05	8.76e-05	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—CCL2—obesity	3.48e-05	8.72e-05	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—CAV1—obesity	3.47e-05	8.68e-05	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—APOA1—obesity	3.46e-05	8.66e-05	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—IGF1—obesity	3.42e-05	8.57e-05	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—AKT2—obesity	3.42e-05	8.56e-05	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—PIK3CA—obesity	3.37e-05	8.44e-05	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—ESR1—obesity	3.34e-05	8.37e-05	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—F2—obesity	3.3e-05	8.26e-05	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—PRKCB—obesity	3.3e-05	8.26e-05	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—PIK3CD—obesity	3.28e-05	8.23e-05	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—PIK3CB—obesity	3.26e-05	8.18e-05	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—MTOR—obesity	3.26e-05	8.18e-05	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—BAD—obesity	3.26e-05	8.17e-05	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR downstream signaling—PIK3CA—obesity	3.25e-05	8.15e-05	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—SERPINE1—obesity	3.25e-05	8.14e-05	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—TYK2—obesity	3.16e-05	7.91e-05	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—PIK3CG—obesity	3.16e-05	7.91e-05	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—RHOA—obesity	3.13e-05	7.85e-05	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—IRS1—obesity	3.12e-05	7.82e-05	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—PIK3R1—obesity	3.1e-05	7.77e-05	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—NOS3—obesity	3.1e-05	7.77e-05	CbGpPWpGaD
Nalbuphine—OPRD1—GPCR downstream signaling—AKT1—obesity	3.03e-05	7.59e-05	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—POMC—obesity	3e-05	7.53e-05	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—INS—obesity	2.99e-05	7.49e-05	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—IL6—obesity	2.98e-05	7.47e-05	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—PIK3CA—obesity	2.95e-05	7.4e-05	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—CCL2—obesity	2.94e-05	7.37e-05	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—IGF1—obesity	2.89e-05	7.24e-05	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—AKT2—obesity	2.89e-05	7.24e-05	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—PIK3CB—obesity	2.86e-05	7.17e-05	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—MTOR—obesity	2.86e-05	7.17e-05	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—MMP9—obesity	2.84e-05	7.11e-05	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—PIK3CD—obesity	2.78e-05	6.95e-05	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—MAPK8—obesity	2.76e-05	6.91e-05	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—AKT1—obesity	2.75e-05	6.89e-05	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR downstream signaling—PIK3CA—obesity	2.75e-05	6.89e-05	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—SERPINE1—obesity	2.74e-05	6.88e-05	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—TYK2—obesity	2.67e-05	6.69e-05	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR downstream signaling—AKT1—obesity	2.66e-05	6.66e-05	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—RHOA—obesity	2.65e-05	6.63e-05	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—NOS3—obesity	2.62e-05	6.57e-05	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—PIK3R1—obesity	2.62e-05	6.57e-05	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—IL6—obesity	2.62e-05	6.55e-05	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—STAT3—obesity	2.52e-05	6.32e-05	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—PIK3CA—obesity	2.5e-05	6.25e-05	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—MMP9—obesity	2.49e-05	6.23e-05	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—MAPK8—obesity	2.42e-05	6.06e-05	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—PIK3CB—obesity	2.42e-05	6.06e-05	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—MTOR—obesity	2.42e-05	6.06e-05	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—AKT1—obesity	2.41e-05	6.05e-05	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—MYC—obesity	2.34e-05	5.87e-05	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—TGFB1—obesity	2.34e-05	5.86e-05	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR downstream signaling—AKT1—obesity	2.25e-05	5.63e-05	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—STAT3—obesity	2.21e-05	5.54e-05	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—IL6—obesity	2.21e-05	5.54e-05	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—MMP9—obesity	2.1e-05	5.27e-05	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—MYC—obesity	2.06e-05	5.15e-05	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—TGFB1—obesity	2.05e-05	5.14e-05	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—MAPK8—obesity	2.04e-05	5.12e-05	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—AKT1—obesity	2.04e-05	5.11e-05	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—PIK3CA—obesity	1.99e-05	4.99e-05	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—STAT3—obesity	1.87e-05	4.68e-05	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—IL6—obesity	1.76e-05	4.41e-05	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—PIK3CA—obesity	1.74e-05	4.37e-05	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—MYC—obesity	1.74e-05	4.35e-05	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—TGFB1—obesity	1.73e-05	4.34e-05	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—AKT1—obesity	1.63e-05	4.07e-05	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—IL6—obesity	1.55e-05	3.87e-05	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—PIK3CA—obesity	1.47e-05	3.69e-05	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—AKT1—obesity	1.43e-05	3.57e-05	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—IL6—obesity	1.31e-05	3.27e-05	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—AKT1—obesity	1.2e-05	3.02e-05	CbGpPWpGaD
